Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Eur J Neurosci. 2011 Mar 31;33(9):1716–1723. doi: 10.1111/j.1460-9568.2011.07663.x

Table 1.

Demographic Characteristics and Drug Use by Study Subjects

CUD+ (N=28) CUD− (N=27) Controls (N=29)
Gender (male/female) 27/1 26/1 25/4
Ethnicity (African-American/Caucasian/Hispanic) 20/5/3 19/5/3 20/8/1
History of cigarette smoking (current or past/never or tried)1 21/7c 21/6c 6/23a,b
Education (years) 13.09 (1.76) 12.69 (1.82) 13.81 (2.02)
Age (years) 45.55 (4.81) 42.47 (8.82) 41.17 (7.32)
Socio-economic status (Hollingshead, 1975) 32.32 (11.03) 33.06 (11.63) 32.90 (13.56)
Non-verbal intellectual functioning: Wechsler Abbreviated 9.43 (3.72) 9.92 (3.06) 11.03 (2.72)
Scale of Intelligence: Matrix Reasoning scaled score (Wechsler, 1999)
Self-reported state depression (Beck et al., 1996)2 7.57 (7.56)c 7.63 (6.38)c 1.48 (2.87)a,b
Age at onset of cocaine use (years) 26.68 (5.23) 25.04 (6.47) --
Duration of use (years) 16.56 (7.09) 14.46 (8.80) --
Frequency of use (days/week) last 30 days3 4.23 (2.40)b 1.53 (2.29)a --
Current use in $ per use (min – max, median) last 30 days 62.36 (2–200, 50) 109.23 (0–300, 80) --
Duration of current abstinence (days) (min – max, median)4 2.25 (0–14, 2)b 214.85 (2–2555, 25)a --
Length of longest abstinence (days) (min – max, median) 869.89 (19–3650, 365) 818.63 (25–2555, 560) --
Total score on the Cocaine Selective Severity Assessment 19.11 (10.84) 15.74 (10.36) --
Scale (measure of withdrawal symptoms; 0–126)
Severity of Dependence Scale (0–15)5 6.61 (3.40)b 8.44 (3.15)a --
Cocaine Craving Questionnaire (0–45)6 22.18 (10.66)b 10.96 (9.58)a --

Note. Values in parentheses are standard deviations unless otherwise indicated.

1

χ2(2)=23.79, p<.001 (Kruskal-Wallis);

2

χ2(2)=25.07, p<.001 (Kruskal-Wallis);

3

Z=−4.00, p<.001 (Mann-Whitney);

4

Z=−5.71, p<.001 (Mann-Whitney);

5

t(53)=−2.08, p<.05;

6

t(53)=4.10, p<.001. Superscript letters designate group differences

a

significantly different from CUD+;

b

significantly different from CUD−;

c

significantly different from control group.